<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="34fff06e-fa45-478a-b136-e019483fa07d"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>
      <content styleCode="bold">Cyclopentolate<br/>Hydrochloride</content>
      <br/>
      <content styleCode="bold">Ophthalmic<br/>Solution<br/>USP<br/>1%</content>
      <br/>
      <content styleCode="bold">Rx only </content>
   </title>
   <effectiveTime value="20220929"/>
   <setId root="ad85b220-6003-4a78-b900-5195ceaf0fd5"/>
   <versionNumber value="15"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="196603781" root="1.3.6.1.4.1.519.1"/>
            <name>Bausch &amp; Lomb Incorporated</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="079587625" root="1.3.6.1.4.1.519.1"/>
                        <name>Bausch &amp; Lomb Incorporated</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="24208-735" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="3d7ad726-6bdd-4f08-b6f7-10f8cfb83567"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20220929"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="24208-735" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Cyclopentolate Hydrochloride</name>
                        <formCode code="C60992" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SOLUTION/ DROPS"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Cyclopentolate Hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="10"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="736I6971TE" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CYCLOPENTOLATE HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="I76F4SHP7J" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CYCLOPENTOLATE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="F5UM2KM3W7" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BENZALKONIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="R57ZHV85D4" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="7FLD91C86K" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>EDETATE DISODIUM</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POTASSIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="45P3261C7T" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CARBONATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="2"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43171" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, DROPPER"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="24208-735-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19940429"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="15"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43171" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, DROPPER"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="24208-735-06" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19940429"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA040075" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19940429"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID_a24e3f93-d88a-45de-981d-5b1adb5c95ba">
               <id root="aa7f899d-d37d-4f0f-80eb-cf5286bab49f"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION </title>
               <text>
                  <paragraph>Cyclopentolate hydrochloride ophthalmic solution USP, 1% is an anticholinergic prepared as a sterile, borate buffered, solution for topical ocular use. The active ingredient is represented by the structural formula:</paragraph>
                  <renderMultiMedia ID="id327030303" referencedObject="ID_557547ae-d4e5-460a-b2aa-83af71a72023"/>
                  <paragraph>Molecular Weight = 327.85<br/>Molecular Formula: C<sub>17</sub>H<sub>25</sub>NO<sub>3</sub> • HCl</paragraph>
                  <paragraph>Established name: cyclopentolate hydrochloride<br/>Chemical name: 2-(Dimethylamino) ethyl 1-hydroxy-α-phenylcyclopentaneacetate hydrochloride</paragraph>
                  <paragraph>
                     <content styleCode="bold">Each mL contains:<br/>Active:</content> cyclopentolate hydrochloride, 10 mg (1%)</paragraph>
                  <paragraph>
                     <content styleCode="bold">Inactives:</content> boric acid, edetate disodium, potassium chloride, purified water. Sodium carbonate and/or hydrochloric acid (to adjust pH). The pH range is between 3.0 and 5.5.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Preservative:</content> benzalkonium chloride 0.01%.</paragraph>
               </text>
               <effectiveTime value="20220929"/>
               <component>
                  <observationMedia ID="ID_557547ae-d4e5-460a-b2aa-83af71a72023">
                     <text>chem</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_ae1bae6f-660b-4905-9205-571ee8f1d343">
               <id root="3ad182b4-606e-4fd3-a259-173a72a55340"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY </title>
               <text>
                  <paragraph>This anticholinergic preparation blocks the responses of the sphincter muscle of the iris and the accommodative muscle of the ciliary body to cholinergic stimulation, producing pupillary dilation (mydriasis) and paralysis of accommodation (cycloplegia). It acts rapidly, but has a shorter duration than atropine. Maximal cycloplegia occurs within 25 to 75 minutes after instillation. Complete recovery of accommodation usually takes 6 to 24 hours. Complete recovery from mydriasis in some individuals may require several days. Heavily pigmented irides may require more doses than lightly pigmented irides.</paragraph>
               </text>
               <effectiveTime value="20220929"/>
            </section>
         </component>
         <component>
            <section ID="ID_8fddd730-a1da-4f07-a03b-d08d9a9aff90">
               <id root="82461cf7-32f0-4372-9f70-12c16674e555"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE </title>
               <text>
                  <paragraph>Cyclopentolate hydrochloride ophthalmic solution is used to produce mydriasis and cycloplegia.</paragraph>
               </text>
               <effectiveTime value="20220929"/>
            </section>
         </component>
         <component>
            <section ID="ID_2ee9cb76-1472-497f-80cc-84ff72e5b00e">
               <id root="256a9e2a-dac7-44b5-985d-963f437daca8"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS </title>
               <text>
                  <paragraph>Hypersensitive to any component of this preparation.</paragraph>
               </text>
               <effectiveTime value="20220929"/>
            </section>
         </component>
         <component>
            <section ID="ID_879cd004-26e5-4262-b125-7542a37cd9a9">
               <id root="196b0c9a-8164-494a-9523-685ab7c948a7"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS </title>
               <text>
                  <paragraph>FOR TOPICAL OPHTHALMIC USE. NOT FOR INJECTION. This preparation may cause Central Nervous System (CNS) disturbances. This is especially true in younger age groups, but may occur at any age, especially with the stronger cyclopentolate hydrochloride solutions. Infants are especially prone to CNS and cardiopulmonary side effects from cyclopentolate. To minimize absorption, use only 1 drop of a 1% cyclopentolate solution per eye, followed by pressure applied over the nasolacrimal sac for two to three minutes. Observe infants closely for at least 30 minutes following instillation.</paragraph>
                  <paragraph>Mydriatics may produce a transient elevation of intraocular pressure.</paragraph>
               </text>
               <effectiveTime value="20220929"/>
            </section>
         </component>
         <component>
            <section ID="ID_c7f47d6c-a039-451d-a366-66d03f738849">
               <id root="fc92e09d-b95f-42a4-8b49-f553d787492d"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS </title>
               <effectiveTime value="20220929"/>
               <component>
                  <section ID="ID_9fba65a0-e155-4ab6-a4c6-c71ab095edff">
                     <id root="ccba69ee-04d8-4cd3-ac2f-f658abd3ea76"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title>General: </title>
                     <text>
                        <paragraph>The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to reduce excessive systemic absorption. Caution should be observed when considering use of this medication in the presence of Down’s syndrome.</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_9985501e-01fa-44e9-b61f-6a0114a3477b">
                     <id root="d6b5e137-aea9-478a-a5d3-fdd44f179e8d"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>Information for Patients: </title>
                     <text>
                        <paragraph>Do not touch dropper tip to any surface, as this may contaminate the solution. A transient burning sensation may occur upon instillation. Patients should be advised not to drive or engage in other hazardous activities while pupils are dilated. Patients may experience sensitivity to light and should protect eyes in bright illumination during dilation. Parents should be warned not to get this preparation in their child’s mouth and to wash their own hands and the child’s hands following administration. Feeding intolerance may follow ophthalmic use of this product in infants. It is recommended that feeding be withheld for four (4) hours after examination.</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_d53fe048-0e0d-481c-8883-dca37ba23022">
                     <id root="ef3d0320-7be2-4d16-9d2a-e7da100a11bf"/>
                     <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
                     <title>Drug Interactions: </title>
                     <text>
                        <paragraph>Cyclopentolate may interfere with the ocular anti-hypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_da3a8fae-4790-4e88-9754-9d70911570e8">
                     <id root="e6da7369-cc7e-4d5e-8c83-2397b74d8f09"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis, Mutagenesis, Impairment of Fertility: </title>
                     <text>
                        <paragraph>Studies in animals or humans have not been conducted to evaluate the carcinogenic potential of cyclopentolate hydrochloride ophthalmic solution, USP.</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_c2d39d37-33a4-47c9-ae33-512e81de9be8">
                     <id root="d1b158f6-e9e3-4cee-8f57-ddfffdb97723"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>Pregnancy: </title>
                     <text>
                        <paragraph>Animal reproduction studies have not been conducted with cyclopentolate. It is also not known whether cyclopentolate can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Cyclopentolate should be administered to a pregnant woman only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_daa2f601-1d5e-44bf-8689-ea6c197d678f">
                     <id root="39d49e82-38b0-4248-9c3d-50d9c9d99d4f"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>Nursing Mothers: </title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when cyclopentolate hydrochloride is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_6040b034-9252-4ea4-90a5-8c2d75bef8d4">
                     <id root="1e12fdc1-af4b-4eb0-ba0b-7db53a5aca66"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric Use: </title>
                     <text>
                        <paragraph>Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances in pediatric patients. Increased susceptibility to cyclopentolate has been reported in infants, young children, and in children with spastic paralysis or brain damage. These disturbances include ataxia, incoherent speech, restlessness, hallucinations, hyperactivity, seizures, disorientation as to time and place, and failure to recognize people. Feeding intolerance and necrotizing enterocolitis (in preterm infants) may follow ophthalmic use of this product in infants. It is recommended that feeding be withheld for four (4) hours after examination. Observe infants closely for at least 30 minutes (see <content styleCode="bold">
                              <linkHtml href="#ID_879cd004-26e5-4262-b125-7542a37cd9a9">WARNINGS</linkHtml>
                           </content>).</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_f452bf0a-877f-4d3b-978e-f7d01fc7accf">
                     <id root="1bdcf171-fddc-4445-952c-9b3a833b2dc5"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>Geriatric Use: </title>
                     <text>
                        <paragraph>No overall differences in safety or effectiveness have been observed between elderly and younger patients.</paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_7f0914c5-d49f-478a-a53e-d2625b2ee929">
               <id root="3eb0216c-f187-4438-98bf-e781893f094c"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS </title>
               <text>
                  <paragraph>
                     <content styleCode="bold">Ocular: </content>Increased intraocular pressure, burning, photophobia, blurred vision, irritation, hyperemia, conjunctivitis, blepharoconjunctivitis, punctate keratitis, synechiae have been reported.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Non-ocular: </content>Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration. These disturbances include ataxia, incoherent speech, restlessness, hallucinations, hyperactivity, seizures, disorientation as to time and place, and failure to recognize people. This drug produces reactions similar to those of other anticholinergic drugs, but the CNS manifestations as noted above are more common. Other toxic manifestations of anticholinergic drugs are skin rash, abdominal distention in infants, necrotizing enterocolitis (in preterm infants), unusual drowsiness, tachycardia, hyperpyrexia, vasodilation, urinary retention, diminished gastrointestinal motility and decreased secretion in salivary and sweat glands, pharynx, bronchi and nasal passages. Severe manifestations of toxicity include coma, medullary paralysis and death.</paragraph>
                  <paragraph>
                     <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Bausch &amp; Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or <linkHtml href="http://www.fda.gov/medwatch">www.fda.gov/medwatch</linkHtml>.</content>
                  </paragraph>
               </text>
               <effectiveTime value="20220929"/>
            </section>
         </component>
         <component>
            <section ID="ID_1717e404-6a7b-46e8-a815-7983eabad4e0">
               <id root="b646faa1-d774-4ca2-bdc6-c7e85c2d267f"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>OVERDOSAGE </title>
               <text>
                  <paragraph>Excessive dosage may produce behavioral disturbances, tachycardia, hyperpyrexia, hypertension, elevated intraocular pressure, vasodilation, urinary retention, diminished gastrointestinal motility and decreased secretion in salivary and sweat glands, pharynx, bronchi and nasal passages. Patients exhibiting signs of overdosage should receive supportive care and monitoring.</paragraph>
               </text>
               <effectiveTime value="20220929"/>
            </section>
         </component>
         <component>
            <section ID="ID_21839471-9ea0-4abe-b83e-9ec3b3cc673f">
               <id root="b8600553-cc3b-43b5-8adb-76b2d9469bfa"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION </title>
               <text>
                  <paragraph>
                     <content styleCode="bold">Adults: </content>Instill one or two drops of 1% solution in the eye which may be repeated in five to ten minutes if necessary. Complete recovery usually occurs in 24 hours. Complete recovery from mydriasis in some individuals may require several days.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Children: </content>Instill one or two drops of 1% solution in the eye, which may be repeated five to ten minutes later by a second application of 1% solution if necessary.</paragraph>
                  <paragraph>Individuals with heavily pigmented irides may require higher strengths.</paragraph>
               </text>
               <effectiveTime value="20220929"/>
            </section>
         </component>
         <component>
            <section ID="ID_aa01b288-efc9-4891-92f1-7222e3547efc">
               <id root="71a029bc-36b1-402d-9f05-d94fc9370826"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED </title>
               <text>
                  <paragraph>Cyclopentolate hydrochloride ophthalmic solution USP, 1% is available in multidose plastic squeeze bottles with a controlled drop tip and red cap in the following sizes:</paragraph>
                  <paragraph>2 mL bottle - NDC 24208-735-01<br/>15 mL bottle - NDC 24208-735-06</paragraph>
               </text>
               <effectiveTime value="20220929"/>
               <component>
                  <section ID="ID_53aaa01b-d806-499c-bc52-bb175513986a">
                     <id root="10979633-5f44-44a6-b534-4930ef0bca4c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Storage: </title>
                     <text>
                        <paragraph>Store between 15°C to 25°C (59°F to 77°F).</paragraph>
                        <renderMultiMedia ID="id-248355165" referencedObject="F1AAA8A6-745A-42E7-AE42-E8DC1627F2A8"/>
                        <paragraph>
                           <content styleCode="bold">KEEP OUT OF REACH OF CHILDREN.</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="bold">Distributed by:</content>
                           <br/>Bausch &amp; Lomb Americas Inc.<br/>Bridgewater, NJ 08807 USA<br/>
                           <br/>
                           <content styleCode="bold">Manufactured by:</content>
                           <br/>Bausch &amp; Lomb Incorporated<br/>Tampa, FL 33637 USA<br/>
                           <br/>© 2022 Bausch &amp; Lomb Incorporated or its affiliates<br/>
                           <br/>Rev. 09/2022</paragraph>
                        <paragraph>9114607 <content styleCode="bold">(Folded)</content>
                           <br/>9114707 <content styleCode="bold">(Flat)</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20220929"/>
                     <component>
                        <observationMedia ID="F1AAA8A6-745A-42E7-AE42-E8DC1627F2A8">
                           <text>do not</text>
                           <value mediaType="image/jpeg" xsi:type="ED">
                              <reference value="bd46c773-d8f6-4b8c-9177-4fd6bbdd4a4a-00.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_2784312a-e37a-432f-8c1e-6fbbf9c1fa73">
               <id root="50a97553-3fb8-4d04-87f6-b126f79c5454"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL</title>
               <text>
                  <renderMultiMedia ID="id592" referencedObject="A0F5453C-626A-4867-9351-E108CC6F63FD"/>
                  <paragraph>
                     <content styleCode="bold">NDC </content>24208-735-01 </paragraph>
                  <paragraph>
                     <content styleCode="bold">Cyclopentolate </content>
                     <br/>
                     <content styleCode="bold">Hydrochloride</content>
                     <br/>
                     <content styleCode="bold">Ophthalmic </content>
                     <br/>
                     <content styleCode="bold">Solution<br/>USP</content>
                     <br/>
                     <content styleCode="bold">1%</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">FOR TOPICAL<br/>OPHTHALMIC USE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">2 mL</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">BAUSCH + LOMB</content>
                  </paragraph>
                  <paragraph>9532302<br/>AB04903</paragraph>
               </text>
               <effectiveTime value="20220929"/>
               <component>
                  <observationMedia ID="A0F5453C-626A-4867-9351-E108CC6F63FD">
                     <text>carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>